These Analysts Lower Their Forecasts On Goldman Sachs After Q3 Results

Goldman Sachs reported Q3 EPS of $17.01 versus $13.08 consensus and revenue of $18.679 billion versus $16.705 billion. The board declared a $5 quarterly dividend, payable Dec. 30, 2026, to shareholders of record Dec. 2. Shares fell 2.2% to $872.79 on Wednesday; RBC lowered its price target to $1,010 from $1,220, while KBW cut its target to $1,100 from $1,130.

Analysis

GS’s negative price response to a large consensus beat is a signal about the durability and composition of earnings, not proof that the quarter was weak. The key question is whether results were driven by repeatable client activity or by volatile, episodic items; without segment results, guidance, and management commentary, the headline beat is not enough to underwrite a higher earnings base. Target reductions reinforce the risk that analysts are discounting sustainability, though price targets are not independent evidence of deteriorating fundamentals.

Over the next 1–3 months, watch revisions to forward earnings and commentary on investment-banking pipelines, trading conditions, and expense growth. A sustained reset in those indicators would matter more than this quarter’s beat. Over 6–18 months, the upside case depends on repeatable fee and trading revenue translating into returns that support capital distributions; the downside is that investors assign a lower multiple to earnings that prove unusually strong or volatile. The dividend declaration is not, by itself, evidence of a change in payout capacity.

Contrarian read: the down move may be an overreaction if forward estimates hold and core businesses show broad-based strength. Conversely, buying solely because reported EPS exceeded consensus risks confusing a backward-looking surprise with improved forward earning power.

Key Decisions for Investors

• Do not chase the reported beat. Wait for the earnings materials and call to verify segment-level drivers, one-off items, forward guidance, and expense trends before adding exposure.
• For an existing GS position, keep sizing tied to forward earnings confidence rather than the headline surprise; reassess if estimate revisions turn negative or management signals weakening activity or higher costs.
• Watch for a conditional bearish setup over the next 1–3 months: if weak post-earnings price action persists alongside falling forward estimates, consider defined-risk downside exposure rather than an outright short. The thesis is weakened if estimates stabilize and the shares recover the post-earnings loss.
• No high-conviction trade is warranted from the supplied information alone. The missing evidence is the earnings-quality breakdown and updated company guidance; analyst target cuts are a watch item, not a standalone catalyst.